Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
san francisco blog main
3
×
san francisco top stories
startups
3
×
biotech
san diego blog main
san diego top stories
san francisco
vc
accelerator
acetylon pharmaceuticals
airbnb
amazon web services (aws)
ambys medicines
artificial intelligence (a.i.)
athelas
atomwise
azacitidine
benchling
beta-thalassemia
biotechnology
boston
cancer
cell therapy
coinbase
constellation pharmaceuticals
coworking
cruise
culture biosciences
dacogen
data analytics
decitabine
detroit blog main
What
startup
3
×
big
biotech
medicines
new
admits
ago
aiming
aims
ambys
approach
based
biotechs
called
classes
combinator
companies
control
deadly
deal
debuted
debuts
developing
diseases
drugs
dug
epigenetic
epigenetics
field
flagship’s
formed
future
incubator
launch
life
liver
make
morning
omega
previously
Language
unset
Current search:
startups
×
" san francisco blog main "
×
startup
×
" new york top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
6 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
